CYP1B1-AS1 Delays the Malignant Progression of Colorectal Cancer by Binding with NOP58
- PMID: 38087130
- DOI: 10.1007/s10620-023-08206-7
CYP1B1-AS1 Delays the Malignant Progression of Colorectal Cancer by Binding with NOP58
Abstract
Background: Colorectal cancer (CRC) is a prevalent type of gastrointestinal cancer, and its poor prognosis is mainly attributed to the occurrence of invasion and metastasis. CYP1B1-AS1, as non-coding RNA, plays an important role in tumorigenesis and progression. However, the mechanism by which CYP1B1-AS1 acts in CRC is not yet understood.
Aims: The objective of this study was to investigate how CYP1B1-AS1 contributes to the development of CRC, and provide a base for CRC diagnosis and treatment.
Methods: RT-qPCR was used to detect the expression level of CYP1B1-AS1 in CRC and adjacent tissues. CCK-8, Edu, scratch healing, and transwell experiments were used to detect the changes of proliferation, migration, and invasion ability of CRC cells after overexpression or knockdown of CYP1B1-AS1 respectively. The RNA binding protein NOP58 combined with CYP1B1-AS1 was verified by RIP and RNA Pull-down experiments. Functional recovery experiments validated the interaction between CYP1B1-AS1 and NOP58 in CRC cells. The changes of EMT-related proteins were detected by Western blot, and the half-life of transcription factor SNAIL mRNA were detected by RT-qPCR after overexpression or knockdown of NOP58.
Results: CYP1B1-AS1 was found to be significantly downregulated in CRC compared to adjacent noncancerous tissues. Experiments conducted in vitro and in vivo confirmed that upregulation of CYP1B1-AS1 significantly inhibited the proliferation, migration, and invasion of CRC cells. In addition, CYP1B1-AS1 can directly bind to NOP58 and negatively regulate NOP58. The effect of overexpression CYP1B1-AS1 was reversed by NOP58 overexpression. NOP58 regulates the EMT process of CRC cells by affecting the stability of EMT-related transcription factor SNAIL mRNA, and then affects the progress of CRC.
Conclusion: This research proves that CYP1B1-AS1 can inhibit the occurrence of EMT in CRC by binding with NOP58, thus delaying the progress of CRC. This finding indicates that CYP1B1-AS1 may be a novel biomarker to improve the diagnosis and treatment of CRC.
Keywords: CYP1B1-AS1; Colorectal cancer; Long noncoding RNA; NOP58; RNA-binding protein.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2'-O-methylation via NOP58 recruitment in colorectal cancer.Mol Cancer. 2020 May 22;19(1):95. doi: 10.1186/s12943-020-01201-w. Mol Cancer. 2020. PMID: 32443980 Free PMC article.
-
Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.Cancer Biomark. 2018;23(1):145-156. doi: 10.3233/CBM-181503. Cancer Biomark. 2018. PMID: 30010111
-
Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.In Vitro Cell Dev Biol Anim. 2019 Sep;55(8):577-585. doi: 10.1007/s11626-019-00376-x. Epub 2019 Jul 22. In Vitro Cell Dev Biol Anim. 2019. PMID: 31332696
-
Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A.Biosci Rep. 2019 Nov 29;39(11):BSR20192550. doi: 10.1042/BSR20192550. Biosci Rep. 2019. PMID: 31696213 Free PMC article.
-
LncRNA GAS6-AS1 facilitates tumorigenesis and metastasis of colorectal cancer by regulating TRIM14 through miR-370-3p/miR-1296-5p and FUS.J Transl Med. 2022 Aug 12;20(1):356. doi: 10.1186/s12967-022-03550-0. J Transl Med. 2022. PMID: 35962353 Free PMC article.
Cited by
-
The functions and mechanisms of long non-coding RNA in colorectal cancer.Front Oncol. 2024 Jul 4;14:1419972. doi: 10.3389/fonc.2024.1419972. eCollection 2024. Front Oncol. 2024. PMID: 39026978 Free PMC article. Review.
References
-
- Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin 2021;71:209–249. - PubMed
-
- Miller KD, Nogueira L, Mariotto AB et al. Cancer treatment and survivorship statistics, 2019. CA: Cancer J Clin 2019;69:363–85. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous